Christian Chang | Health Science | Research Excellence Award

Published on by Applied Scientist

Research Excellence Award

Christian Chang
Medical College of Wisconsin, United States

Christian Chang
Affiliation Medical College of Wisconsin
Country United States
Scopus ID 58592667700
Documents 2
Citations 8
h-index 1
Subject Area Health Science
Event Applied Scientist Awards
ORCID 0000-0003-4612-8037

Christian Chang of the Medical College of Wisconsin, United States, with a focus on documented scholarly output and research visibility in the health sciences. Bibliometric indicators such as publication records, citations, and the h-index are commonly used as complementary measures for examining research influence and should be interpreted within the context of disciplinary practices and career stage. The Research Excellence Award recognizes researchers whose scholarly work demonstrates meaningful contributions to the advancement of knowledge, scientific communication, and evidence-based practice.[1][2]

Abstract

Christian Chang is a health science researcher affiliated with the Medical College of Wisconsin in the United States. The available bibliometric profile records two documents, eight citations, and an h-index of one in Scopus. These indicators provide a quantitative snapshot of scholarly visibility and should be considered alongside the substance, originality, methodological quality, and relevance of the research itself.[1] The Research Excellence Award profile therefore reflects a balanced academic perspective that recognizes documented research activity while acknowledging the importance of qualitative assessment in evaluating scholarly contribution.[3]

Keywords

Research Excellence Award; Christian Chang; Medical College of Wisconsin; Health Science; Bibliometrics; Research Impact; Scholarly Communication

Introduction

Research excellence is a multidimensional concept encompassing the generation of reliable knowledge, methodological rigor, scholarly communication, and the potential contribution of research to scientific and professional communities. In health science, research may also be evaluated according to its relevance to clinical practice, public health, biomedical understanding, and the development of improved approaches to health-related challenges.[1][2] Responsible research assessment frameworks therefore recommend that quantitative metrics should support, rather than replace, expert evaluation of the quality and significance of scholarly work.[3]

Research Profile

Christian Chang is associated with the Medical College of Wisconsin, a United States-based academic and health sciences institution. The research profile is categorized within the broad subject area of Health Science. According to the available Scopus author information, the profile includes two indexed documents, eight citations, and an h-index of one.[1]

The recorded indicators represent a limited but measurable body of indexed scholarly activity. Because bibliometric measures are influenced by field-specific citation patterns and publication timelines, the available metrics should be interpreted as descriptive indicators rather than as standalone measures of research quality.[2][3]

Research Contributions

Within the health sciences, scholarly contributions may encompass original research, clinical or translational investigations, methodological studies, interdisciplinary collaboration, and the dissemination of findings through peer-reviewed publication. The available profile information establishes Christian Chang’s participation in indexed scholarly research and provides a basis for evaluating the research record through both quantitative and qualitative evidence.[3][4]

Publications

The Scopus profile associated with Christian Chang records two documents. The indexed publication record forms the principal quantitative basis for examining the documented scholarly output presented in this recognition profile.[1]

Publication assessment should extend beyond the number of documents to include the scientific contribution, peer-review context, research design, authorship role, journal quality, and relevance to the field. Where specific publication-level information and DOI records are available, those records can provide additional evidence for evaluating the reach and scholarly significance of individual studies.

Research Impact

The available bibliometric profile records eight citations and an h-index of one. These measures indicate that the indexed publication record has received documented scholarly attention. Citation-based indicators can assist in describing research visibility, but they should be interpreted in relation to disciplinary norms, publication age, and the characteristics of the relevant research community.[5][2] Consequently, a balanced evaluation of research excellence benefits from considering both measurable scholarly indicators and the broader significance of the research contribution.[3][4]

Award Suitability

Christian Chang’s documented affiliation with the Medical College of Wisconsin and indexed scholarly record in Health Science provide a foundation for consideration under a research excellence recognition framework. The available record includes two documents, eight citations, and an h-index of one, offering verifiable evidence of scholarly activity and citation-based visibility.[1]

Conclusion

The Research Excellence Award profile for Christian Chang presents a documented academic record associated with the Medical College of Wisconsin in the United States and the broad field of Health Science. A complete evaluation of research excellence should combine these indicators with qualitative evidence concerning the originality, rigor, relevance, and influence of the underlying scholarly work. Such an integrated approach provides a more balanced representation of academic contribution and is consistent with responsible principles for research assessment.[3][4]

References

  1. Elsevier. (n.d.). Scopus author details: Christian Chang, Author ID 58592667700. Scopus.
    https://www.scopus.com/pages/authors/58592667700
  2. JM Moris, R Curtis, CJ Chang, & et al. (2026). Utilizing nasal breathing during aerobic exercise is associated with a higher cerebral blood flow volume. https://www.sciencedirect.com/science/article/pii/S2950273X26000433
  3. HA Turner, CJ Chang, & et al. (2023). Evaluation and Management of Exertional Rhabdomyolysis Following a Spin Class.
    https://journals.humankinetics.com/view/journals/ijatt/29/3/article-p136.xml
  4. K Allen, R Curtis, CJ Chang, & et al. (2024). Enhancing Oxygen Uptake Efficiency Through Nasal Breathing in Aerobic Exercise
    https://digitalcommons.wku.edu/ijesab/vol2/iss16/107
  5. R Curtis, JM Moris, CJ Chang, & et al. (2024). Glutathione Peroxidase Enzymatic Activity in Response to Transient Hypercapnic Aerobic Exercise.
    https://digitalcommons.wku.edu/ijesab/vol2/iss16/101/

Jinshun Xu | Biomedical Nanotechnology | Innovative Research Award

Published on by Applied Scientist

Innovative Research Award

Jinshun Xu
Sichuan Cancer Hospital, China

Jinshun Xu
Affiliation Sichuan Cancer Hospital
Country China
Scopus ID 56666258500
Documents 57
Citations 809
h-index 15
Subject Area Biomedical Nanotechnology
Event Applied Scientist Awards
ORCID 0000-0003-2420-2320

Jinshun Xu is a Chinese physician-scientist and researcher at Sichuan Cancer Hospital whose work focuses on biomedical nanotechnology, ultrasound medicine, cancer imaging, and image-guided therapeutic interventions. His research has contributed to the development of microwave-responsive nanocarriers, ultrasound-mediated drug delivery systems, and immune-enhanced cancer therapies. These contributions reflect the type of interdisciplinary innovation and translational research recognized by the Innovative Research Award.[1]

Abstract

Jinshun Xu is a Chinese physician-scientist whose research focuses on the convergence of biomedical nanotechnology, ultrasound medicine, molecular imaging, and minimally invasive oncologic therapies. His investigations have emphasized microwave-responsive nanocarriers, ultrasound-mediated drug delivery systems, image-guided ablation strategies, and immune-enhancing therapeutic platforms. Through multidisciplinary collaborations, he has contributed to the development of advanced treatment approaches for hepatocellular carcinoma, breast cancer, prostate cancer, and other malignancies. His publication record, citation performance, and leadership of nationally and provincially funded research projects demonstrate substantial scientific productivity and translational relevance.[2]

Keywords

Biomedical Nanotechnology; Ultrasound Medicine; Cancer Imaging; Microwave Ablation; Nanocarriers; Immunotherapy; Molecular Imaging; Drug Delivery Systems; Oncology Research; Translational Medicine.

Introduction

Modern cancer research increasingly depends upon interdisciplinary approaches that integrate engineering, nanotechnology, imaging sciences, and clinical medicine. Researchers working at these interfaces play an important role in advancing precision medicine and minimally invasive therapeutic strategies. Jinshun Xu’s academic career reflects this multidisciplinary paradigm through contributions spanning ultrasound-guided interventions, microwave-responsive therapeutic systems, and nano-enabled cancer treatments.[3]

Research Profile

Jinshun Xu currently serves as Deputy Director of the Department of Ultrasound Medicine at Sichuan Cancer Hospital. His research program encompasses molecular imaging, nanomedicine, thermal ablation technologies, targeted drug delivery, ultrasound-responsive biomaterials, and cancer immunotherapy. He has led multiple competitive research projects funded by provincial foundations, university programs, and national scientific agencies, demonstrating sustained research leadership.[1]

Research Contributions

Jinshun Xu’s work involves the design of microwave-responsive nanoplatforms capable of enhancing local tumor ablation while simultaneously promoting immune activation. These systems have been investigated as strategies to improve treatment efficacy and address metastatic disease progression through combined thermal, dynamic, and immunotherapeutic mechanisms.[4]

Publications

  • Microwave ablation of benign breast tumors: a prospective study with minimum 12 months follow-up (International Journal of Hyperthermia, 2018).
  • Ultrasound-responsive nanocarriers for cancer therapy: Physiochemical features-directed design (Journal of Controlled Release, 2025).
  • Review of clinical tumor ablation advance in Asia (International Journal of Hyperthermia, 2021).
  • Phase-transitional Fe3O4/perfluorohexane microspheres for magnetic droplet vaporization (Theranostics, 2017).[5]

Research Impact

Jinshun Xu’s research is reflected in a Scopus profile reporting 57 indexed documents, more than 800 citations, and an h-index of 15. These indicators suggest consistent scholarly engagement and recognition within biomedical engineering, oncology, imaging science, and nanomedicine communities.[1]

Beyond publication metrics, his work has contributed to the advancement of translational technologies that bridge laboratory innovation and clinical implementation.[4]

Award Suitability

Jinshun Xu demonstrates characteristics commonly associated with candidates for the Innovative Research Award. These include interdisciplinary scientific contributions, leadership in externally funded research programs, development of emerging therapeutic technologies, and publication of influential work in high-impact journals. His investigations into microwave-responsive nanomedicine, ultrasound-guided interventions, and immune-enhanced cancer therapies align closely with contemporary priorities in translational biomedical research.[2][1]

Conclusion

Jinshun Xu has established a research career characterized by innovation in biomedical nanotechnology, ultrasound medicine, and image-guided cancer therapy. His contributions span fundamental nanomaterial development, translational therapeutic engineering, and clinical evaluation of advanced treatment approaches. Through a combination of scientific productivity, collaborative research leadership, and translational impact, he represents a strong candidate for recognition through the Innovative Research Award.

References

  1. Elsevier. (n.d.). Scopus author details: Jinshun Xu, Author ID 56666258500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56666258500
  2. Xu J., et al. (2026). Microwave-responsive nanocarrier-unlocked thermal-dynamic-immunotherapy: Rational physicochemical design-determined immunomodulation. Coordination Chemistry Reviews.
    https://doi.org/10.1016/j.ccr.2026.218126
  3. Xu J., et al. (2026). Magnetic Hyperthermia Ablation of Tumors Using Injectable Fe3O4/Calcium Phosphate Cement. ACS applied materials & interfaces
    https://pubs.acs.org/doi/abs/10.1021/acsami.5b02077
  4. Cheng X., Xu J., et al. (2024). A tumor-homing nanoframework for synergistic microwave tumor ablation and provoking strong anticancer immunity against metastasis. ACS Nano.
    https://pubs.acs.org/doi/abs/10.1021/acsnano.4c10603
  5. Xu J., Cheng X., et al. (2019). Microwave responsive nanoplatform via p-selectin mediated drug delivery for treatment of hepatocellular carcinoma with distant metastasis. Nano Letters.
    https://pubs.acs.org/doi/abs/10.1021/acs.nanolett.8b05202